These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 6760234)
21. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. Ketter TA; Post RM; Parekh PI; Worthington K J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374 [TBL] [Abstract][Full Text] [Related]
22. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics. Fangmann P; Assion HJ; Juckel G; González CA; López-Muñoz F J Clin Psychopharmacol; 2008 Feb; 28(1):1-4. PubMed ID: 18204333 [No Abstract] [Full Text] [Related]
24. Combined use of tricyclic antidepressants and monoamine oxidase inhibitors. Lader M J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):20-4. PubMed ID: 6355073 [TBL] [Abstract][Full Text] [Related]
25. Serotonin agonists and beta-adrenergic agonists as a treatment for depressive disorder: a direct clinical application. Stahl SM Psychopharmacol Bull; 1985; 21(1):43-7. PubMed ID: 2984713 [No Abstract] [Full Text] [Related]
26. The combined use of MAOIs and tricyclics. White K; Simpson G J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):67-9. PubMed ID: 6376486 [TBL] [Abstract][Full Text] [Related]
27. [Duration of antidepressive treatments]. Villeneuve A Encephale; 1992 Sep; 18 Spec No 4():517-20. PubMed ID: 1308848 [TBL] [Abstract][Full Text] [Related]
28. Use of TCA-MAOI combinations. Am J Hosp Pharm; 1978 Jan; 35(1):21, 24-5. PubMed ID: 623115 [No Abstract] [Full Text] [Related]
29. Which antidepressant? Benaim S Br J Clin Pract; 1990 May; 44(5):196-200. PubMed ID: 2390444 [No Abstract] [Full Text] [Related]
30. [The tolerability and efficacy of combined antidepressant therapy: literature review]. Taleb M; Gorwood P; Bouleau JH; Rouillon F Encephale; 1996; 22(6):450-60. PubMed ID: 10901838 [TBL] [Abstract][Full Text] [Related]
32. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia. Pohl R; Berchou R; Rainey JM J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863 [TBL] [Abstract][Full Text] [Related]
33. The psychopharmacologic treatment of major depression. Stoudemire A J Med Assoc Ga; 1988 Nov; 77(11):821-4. PubMed ID: 3142958 [No Abstract] [Full Text] [Related]
34. Research overview of drug therapy in recurrent and chronic depression. Prien RF Adv Biochem Psychopharmacol; 1985; 40():121-30. PubMed ID: 3895838 [No Abstract] [Full Text] [Related]
35. Monoamine oxidase inhibitors. Lippmann S Am Fam Physician; 1986 Jul; 34(1):113-9. PubMed ID: 3728254 [TBL] [Abstract][Full Text] [Related]
36. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study. Shahal B; Piel E; Mecz L; Kremer I; Klein E Biol Psychiatry; 1996 Dec; 40(11):1181-3. PubMed ID: 8931923 [No Abstract] [Full Text] [Related]
37. The relationship of antiobsessional and antidepressant effects of tricyclic antidepressants. Mavissakalian M; Turner SM; Michelson L; Jacob R Psychopharmacol Bull; 1986; 22(1):161-6. PubMed ID: 3523574 [No Abstract] [Full Text] [Related]